For: | Bartram SA, Peaston RT, Rawlings DJ, Walshaw D, Francis RM, Thompson NP. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn’s disease. World J Gastroenterol 2006; 12(35): 5680-5686 [PMID: 17007022 DOI: 10.3748/wjg.v12.i35.5680] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i35/5680.htm |
Number | Citing Articles |
1 |
I. Blumenstein, B. Siegmund, E. Sonnenberg. Geschlechtsspezifische Unterschiede bei chronisch-entzündlichen Darmerkrankungen. Der Gastroenterologe 2019; 14(2): 102 doi: 10.1007/s11377-019-0323-8
|
2 |
Daniel Sánchez Cano, Ricardo Ruiz-Villaverde, M. Carmen Olvera Porcel, José Luis Callejas Rubio, Carlos Cardeña Pérez, María Gómez García, Jorge González Calvin, Norberto Ortego Centeno. Valoración de la densidad mineral ósea, marcadores de remodelado óseo, el sistema OPG/RANKL y el sTNF-RI en la enfermedad de Crohn. Gastroenterología y Hepatología 2011; 34(1): 3 doi: 10.1016/j.gastrohep.2010.10.006
|
3 |
Jochen Klaus, M M Haenle, C Schröter, G Adler, G von Boyen, M Reinshagen, C von Tirpitz. A Single Dose of Intravenous Zoledronate Prevents Glucocorticoid Therapy-Associated Bone Loss in Acute Flare of Crohn's Disease, a Randomized Controlled Trial. American Journal of Gastroenterology 2011; 106(4): 786 doi: 10.1038/ajg.2011.59
|
4 |
Kohei Wagatsuma, Satoshi Yamada, Misora Ao, Minoru Matsuura, Hidemi Tsuji, Tomoya Iida, Kentaro Miyamoto, Kentaro Oka, Motomichi Takahashi, Kiyoshi Tanaka, Hiroshi Nakase. Diversity of Gut Microbiota Affecting Serum Level of Undercarboxylated Osteocalcin in Patients with Crohn’s Disease. Nutrients 2019; 11(7): 1541 doi: 10.3390/nu11071541
|
5 |
Ma Angeles Vázquez, Enrique Lopez, Ma José Montoya, Mercè Giner, Ramón Pérez-Temprano, Ramón Pérez-Cano. Vertebral fractures in patients with inflammatory bowel disease COMPARED with a healthy population: a prospective case-control study. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-47
|
6 |
Sjoerd F. Bakker, Vincent K. Dik, Birgit I. Witte, Paul Lips, Jan C. Roos, Adriaan A. Van Bodegraven. Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation. Journal of Crohn's and Colitis 2013; 7(5): 377 doi: 10.1016/j.crohns.2012.06.003
|
7 |
Isaac Soo, Jesse Siffledeen, Kerry Siminoski, Bob McQueen, Richard N. Fedorak. Risedronate improves bone mineral density in Crohn's disease: A two year randomized controlled clinical trial. Journal of Crohn's and Colitis 2012; 6(7): 777 doi: 10.1016/j.crohns.2012.01.004
|
8 |
Regina Irwin, Sandi Raehtz, Narayanan Parameswaran, Laura R. McCabe. Intestinal inflammation without weight loss decreases bone density and growth. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2016; 311(6): R1149 doi: 10.1152/ajpregu.00051.2016
|
9 |
Andrea Becciolini, Eleonora Di Donato, Gianluca Lucchini, Daniele Santilli, Flavio Mozzani, Michele Riva, Alarico Ariani. Imaging in the Assessment of Musculoskeletal Manifestations Associated with Inflammatory Bowel Disease. Gastroenterology Insights 2021; 12(1): 100 doi: 10.3390/gastroent12010010
|
10 |
Fiona D.M. Van Schaik, Marc A.M.T. Verhagen, Peter D. Siersema, Bas Oldenburg. High prevalence of low bone mineral density in patients with Inflammatory Bowel Disease in the setting of a peripheral Dutch hospital. Journal of Crohn's and Colitis 2008; 2(3): 208 doi: 10.1016/j.crohns.2008.03.002
|
11 |
L. Kallel, S. Chakroun, S. Matri, N. Ben Mustapha, S. Karoui, H. Sahli, M. Fekih, J. Boubaker, S. Sellami, A. Filali. Facteurs de risque de perte osseuse chez les patients atteints de maladie de Crohn. Journal Africain d'Hépato-Gastroentérologie 2008; 2(4): 147 doi: 10.1007/S12157-008-0053-X
|
12 |
Rachel A. Kramer, Babette S. Zemel, Jessica L. Arvay-Nezu, Virginia A. Stallings, Mary B. Leonard, Barbara A. Haber. Bone Health in a Nonjaundiced Population of Children with Biliary Atresia. Gastroenterology Research and Practice 2009; 2009: 1 doi: 10.1155/2009/387029
|
13 |
I.M. Haeck, N.A.T. Hamdy, L. Timmer-de Mik, E.G.W.M. Lentjes, H.J.J. Verhaar, M.J. Knol, M.S. de Bruin-Weller, C.A.F.M. Bruijnzeel-Koomen. Low bone mineral density in adult patients with moderate to severe atopic dermatitis. British Journal of Dermatology 2009; 161(6): 1248 doi: 10.1111/j.1365-2133.2009.09327.x
|
14 |
C. L. NOBLE, J. MCCULLOUGH, W. HO, C. W. LEES, E. NIMMO, H. DRUMMOND, S. BEAR, J. HANNAN, C. MILLAR, S. H. RALSTON, J. SATSANGI. Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2008; 27(7): 588 doi: 10.1111/j.1365-2036.2008.03599.x
|
15 |
Ming-Huei Chen, Jiaan-Der Wang, Chia-Man Chou, Chieh-Chung Lin. Factors Determining Bone Mineral Density in Patients with Biliary Atresia after a Successful Kasai Operation. Pediatrics & Neonatology 2017; 58(2): 128 doi: 10.1016/j.pedneo.2016.01.007
|
16 |
Laura Harris, Patricia Senagore, Vincent B. Young, Laura R. McCabe. Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009; 296(5): G1020 doi: 10.1152/ajpgi.90696.2008
|
17 |
Hao Wei, Yihan Zhao, Lisha Xiang. Bone health in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2023; 17(9): 921 doi: 10.1080/17474124.2023.2248874
|
18 |
Pál Miheller, Györgyi Müzes, Károly Rácz, Anna Blázovits, Péter Lakatos, László Herszényi, Zsolt Tulassay. Changes of OPG and RANKL concentrations in Crohnʼs disease after infliximab therapy. Inflammatory Bowel Diseases 2007; 13(11): 1379 doi: 10.1002/ibd.20234
|
19 |
Anne Marie Sbrocchi, Sylviane Forget, Diane Laforte, E. Michel Azouz, Celia Rodd. Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease. Pediatrics International 2010; 52(5): 754 doi: 10.1111/j.1442-200X.2010.03174.x
|
20 |
Jens Walldorf, Annette Krummenerl, Kristin Engler, Juliane Busch, Matthias M. Dollinger, Thomas Seufferlein, Jörg G. Albert. Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients?. Journal of Crohn's and Colitis 2013; 7(11): 901 doi: 10.1016/j.crohns.2012.12.008
|
21 |
Rebecca J Hill, Denise SK Brookes, Peter J Lewindon, Geoffrey D Withers, Looi C Ee, Frances L Connor, Geoffrey J Cleghorn, Peter SW Davies. Bone Health in Children With Inflammatory Bowel Disease: Adjusting for Bone Age. Journal of Pediatric Gastroenterology and Nutrition 2009; 48(5): 538 doi: 10.1097/MPG.0b013e31818cb4b6
|
22 |
Ashish Atreja, Ashish Aggarwal, Angelo A. Licata, Bret A. Lashner. Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines. The Scientific World Journal 2012; 2012: 1 doi: 10.1100/2012/807438
|
23 |
Elena Sonnenberg, Alica Kubesch-Grün. Gender-Medizin bei chronisch entzündlicher Darmerkrankung. Die Gastroenterologie 2023; 18(6): 455 doi: 10.1007/s11377-023-00738-8
|
24 |
Kylie E. Whitten, Steven T. Leach, Timothy D. Bohane, Helen J. Woodhead, Andrew S. Day. Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease. Journal of Gastroenterology 2010; 45(4): 399 doi: 10.1007/s00535-009-0165-0
|
25 |
Jan Bilski, Bartosz Brzozowski, Agnieszka Mazur-Bialy, Zbigniew Sliwowski, Tomasz Brzozowski. The Role of Physical Exercise in Inflammatory Bowel Disease. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/429031
|
26 |
Irina Blumenstein, Elena Sonnenberg. Sex- and gender-related differences in inflammatory bowel diseases. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1199687
|
27 |
Susanne Bechtold, Martin Alberer, Tina Arenz, Stefanie Putzker, Birgit Filipiak-Pittroff, Hans Peter Schwarz, Sibylle Koletzko. Reduced muscle mass and bone size in pediatric patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2010; 16(2): 216 doi: 10.1002/ibd.21021
|
28 |
Neeraj Narula, John K. Marshall. Management of inflammatory bowel disease with vitamin D: Beyond bone health. Journal of Crohn's and Colitis 2012; 6(4): 397 doi: 10.1016/j.crohns.2011.10.015
|
29 |
A.-L. Pelletier, G. Hayem. Manifestations osseuses et articulaires au cours des maladies inflammatoires chroniques intestinales. EMC - Gastro-entérologie 2012; 7(1): 1 doi: 10.1016/S1155-1968(12)53912-X
|
30 |
Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Anna Maria Rychter, Agnieszka Zawada, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak. Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2021; 10(7): 1515 doi: 10.3390/jcm10071515
|
31 |
V. A. Akhmedov, T. I. Melikov. Prospects for application of physical exercises and phytotherapy in patients with ulcerative colitis. Medical alphabet 2020; (10): 22 doi: 10.33667/2078-5631-2020-10-22-24
|
32 |
A. Kuwabara, K. Tanaka, N. Tsugawa, H. Nakase, H. Tsuji, K. Shide, M. Kamao, T. Chiba, N. Inagaki, T. Okano, S. Kido. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporosis International 2009; 20(6): 935 doi: 10.1007/s00198-008-0764-2
|
33 |
Arjuna Priyadarsin de Silva, Aranjan Lionel Karunanayake, Thalahitiya Gamaralalage Iruka Dissanayaka, Anuradha Supun Dassanayake, Hewa Kattadi Kankanamgae Tilak Duminda, Arunasalam Pathmeswaran, Ananda Rajitha Wickramasinghe, Hithanadura Janaka de Silva. Osteoporosis in adult Sri Lankan inflammatory bowel disease patients. World Journal of Gastroenterology 2009; 15(28): 3528-3531 doi: 10.3748/wjg.15.3528
|
34 |
Yaqot N Baban, Christopher M Edicheria, Joseph Joseph, Parneet Kaur, Jihan A Mostafa. Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines. Cureus 2021; doi: 10.7759/cureus.20564
|